Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
391.5 USD | -0.50% | -1.01% | -3.52% |
Apr. 18 | Vertex Pharmaceuticals Says FDA Granted Rolling Review of Suzetrigine to Treat Acute Pain | MT |
Apr. 17 | UBS Adjusts Vertex Pharmaceuticals Price Target to $466 From $498, Maintains Buy Rating | MT |
Filters
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated